Columbia Advisory Partners’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.8K | Buy |
36,730
+200
| +0.5% | +$48 | 0.01% | 80 |
|
|
2025
Q1 | $7.2K | Buy |
36,530
+20,110
| +122% | +$3.96K | 0.01% | 72 |
|
|
2024
Q4 | $8.85K | Sell |
16,420
-15,000
| -48% | -$8.08K | 0.01% | 64 |
|
|
2024
Q3 | $29.9K | Buy |
31,420
+3,333
| +12% | +$3.17K | 0.03% | 57 |
|
|
2024
Q2 | $27.4K | Buy |
28,087
+12,502
| +80% | +$12.2K | 0.03% | 52 |
|
|
2024
Q1 | $24.6K | Buy |
+15,585
| New | +$24.6K | 0.03% | 50 |
|